Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide Oral Solution for Meniere's Disease
NCT06765993Phase 3Not yet recruiting
- Sponsor
- Lunan Better Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Isosorbide oral solution (Lunan Better Pharmaceutical) in Meniere's disease (MD), sponsored by Lunan Better Pharmaceutical Co., Ltd.. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
Isosorbide oral solution (Lunan Better Pharmaceutical)
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT06765993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06765993.